Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Statistical Measurement [Domain] Statistical Measurement [Domain] Clinical trials Accrued Clinical Trials Fee, Current Accrued Clinical Trials Fee, Current Schedule Of Shares Reserved For Future Issuance Schedule Of Shares Reserved For Future Issuance [Table Text Block] Schedule Of Shares Reserved For Future Issuance Thereafter Lessee, Operating Lease, Liability, to be Paid, after Year Five Number of renewal options Lessee, Operating Lease, Number Of Renewal Options Lessee, Operating Lease, Number Of Renewal Options Award Timing Predetermined Award Timing Predetermined [Flag] Related Party Transaction [Axis] Related Party Transaction [Axis] 2026, for the remainder of the year Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Additional advance paid Additional Advance Paid Additional Advance Paid Asset Class [Axis] Asset Class [Axis] Entity File Number Entity File Number Additional Paid-in Capital Additional Paid-in Capital [Member] Number of votes per common stock Number Of Votes Per Common Share Number Of Votes Per Common Share Tabular List, Table Tabular List [Table Text Block] Leases [Abstract] Other Financial Statement information Additional Financial Information Disclosure [Text Block] Schedule of Other Noncurrent Liabilities Other Noncurrent Liabilities [Table Text Block] 2030 Lessor, Operating Lease, Payment to be Received, Year Four Recent Accounting Standards New Accounting Pronouncements, Policy [Policy Text Block] Accounts payable Increase (Decrease) in Accounts Payable Interest income Interest Income (Expense), Nonoperating Net settlement of restricted stock units for employee taxes Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Net loss per share, basic (in dollars per share) Earnings Per Share, Basic Adjustment to Compensation: Adjustment to Compensation [Axis] GeneFab Transaction Related Parties Related Party Transactions Disclosure [Text Block] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Common stock reserved for future issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance Stock, Class of Stock [Table] Stock, Class of Stock [Table] Schedule of Segment Reporting Information, by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Issuance of common stock for vesting of restricted stock units (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Schedule of Cash, Cash Equivalents and Investments Cash, Cash Equivalent, and Investment [Table Text Block] Consideration received in collaborative development agreement Revenue, Remaining Performance Obligation, Amount Adjustment to Compensation, Amount Adjustment to Compensation Amount Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Stock options issued and outstanding Stock options issued and outstanding Share-Based Payment Arrangement, Option [Member] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Cash dividends declared and paid, common stock Dividends, Common Stock, Cash Computer equipment and software Computer Equipment and Software [Member] Computer Equipment and Software TOTAL STOCKHOLDERS’ EQUITY Beginning balance Ending balance Equity, Attributable to Parent Insider Trading Policies and Procedures [Line Items] Term of agreement (in years) Research and Development Expense, Term of Agreement Research and Development Expense, Term of Agreement Total stock-based compensation Share-Based Payment Arrangement, Expense BlueRock BlueRock [Member] BlueRock Schedule of Property and Equipment, Net Property, Plant and Equipment [Table Text Block] Common stock, authorized (in shares) Common Stock, Shares Authorized CURRENT ASSETS Assets, Current [Abstract] TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Concentration of Credit Risk And Concentration of Business Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Cover [Abstract] Decrease in operating lease right-of-use assets resulting from lease remeasurement Decrease in operating lease right-of-use assets resulting from lease remeasurement Increase (Decrease) In Operating Lease, Right-Of-Use Assets, Remeasurement Increase (Decrease) In Operating Lease, Right-Of-Use Assets, Remeasurement Maximum Maximum [Member] General and administrative General and Administrative Expense [Member] Accounting Policies [Abstract] Schedule of Maturities of Lease Liabilities Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Original grant amount multiplier Government Assistance, Transaction Duration, Royalty Payment Threshold, Original Grant Amount Multiplier Government Assistance, Transaction Duration, Royalty Payment Threshold, Original Grant Amount Multiplier Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Pay vs Performance Disclosure [Line Items] Total lease liabilities Operating Lease, Liability Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Total undiscounted sublease payments Total undiscounted sublease payments Lessor, Operating Lease, Payment to be Received Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Entity Shell Company Entity Shell Company Other non-current liabilities Total other non-current liabilities Other Liabilities, Noncurrent Proceeds from sale of property and equipment Proceeds from Sale of Property, Plant, and Equipment Deferred revenue - related party Increase (Decrease) in Deferred Revenue Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Statement of Cash Flows [Abstract] Company Selected Measure Amount Company Selected Measure Amount 2029 Lessee, Operating Lease, Liability, to be Paid, Year Three Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Schedule of Prepaid Expenses and Other Current Assets Schedule of Other Current Assets [Table Text Block] Name Measure Name Net loss Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent Letter of Credit Letter of Credit [Member] Schedule of Share-Based Payment Arrangement, Expensed and Capitalized, Amount Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Operating lease liabilities, current Operating Lease, Liability, Current Class of Stock [Line Items] Class of Stock [Line Items] Document Fiscal Period Focus Document Fiscal Period Focus Prepayment credit Lessor, Operating Lease, Payment to be Received, Prepayment Credit Lessor, Operating Lease, Payment to be Received, Prepayment Credit Series A redeemable convertible preferred stock, authorized (in shares) Temporary Equity, Shares Authorized Award Timing Method Award Timing Method [Text Block] Furniture and fixtures Furniture and Fixtures [Member] Award Type [Axis] Award Type [Axis] Legal Entity [Axis] Legal Entity [Axis] TOTAL ASSETS Assets Stockholder approval, percentage of common stock oustanding Sale Of Stock, Issuance, Stockholder Approval, Percentage Of Common Stock Outstanding Sale Of Stock, Issuance, Stockholder Approval, Percentage Of Common Stock Outstanding Costs Incurred On Behalf Of GeneFab Costs Incurred On Behalf Of GeneFab [Member] Costs Incurred On Behalf Of GeneFab Trading Symbol Trading Symbol 2030 Lessee, Operating Lease, Liability, to be Paid, Year Four Covenant, payment of principal amount (in percent) Sale Of Stock, Covenant, Payment Of Principal Amount, Percentage Sale Of Stock, Covenant, Payment Of Principal Amount, Percentage Senti Biosciences, Inc. Senti Biosciences, Inc. [Member] Senti Biosciences, Inc. Deposits Deposits Assets, Current Entity Address, City or Town Entity Address, City or Town CASH FLOWS FROM OPERATING ACTIVITIES Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Statement of Income Location, Balance [Domain] Statement of Income Location, Balance [Domain] Restricted stock units outstanding Restricted Stock Units (RSUs) [Member] Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Entity Emerging Growth Company Entity Emerging Growth Company Warrants to purchase common stock issued in connection with Series A redeemable convertible preferred stock Warrant [Member] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Changes in operating assets and liabilities: Increase (Decrease) in Operating Assets [Abstract] Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Lessee, Operating Lease, Liability, Payment, Due [Abstract] Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] No conversion or exchange, required payment as percentage of as outstanding principal and accrued and unpaid interest Sale Of Stock, No Conversion Or Exchange, Required Payment, Percent Of Interest Sale Of Stock, No Conversion Or Exchange, Required Payment, Percent Of Interest Related Party Related Party [Member] Common stock, outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding 2026, for the remainder of the year Lessor, Operating Lease, Payment to be Received, Remainder of Fiscal Year Plan Name [Axis] Plan Name [Axis] California Institute of Regenerative Medicine (“CIRM”) California Institute of Regenerative Medicine (“CIRM”) [Member] California Institute of Regenerative Medicine (“CIRM”) PEO PEO [Member] Lease Contractual Term [Domain] Lease Contractual Term [Domain] Expected costs and expenses incurred Research and Development Arrangement, Expected Costs Research and Development Arrangement, Expected Costs Interest income Investment Income, Interest SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING INFORMATION: Noncash Investing and Financing Items [Abstract] Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Nature of Operation, Product Information, Concentration of Risk [Table] Nature of Operation, Product Information, Concentration of Risk [Table] Gain on lease modification Remaining amount Gain (Loss) On Lease Modification, Gross Gain (Loss) On Lease Modification, Gross Net proceeds Proceeds from Issuance or Sale of Equity Accumulated Deficit Retained Earnings [Member] Prepaid expenses and other current assets Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Entity Address, Postal Zip Code Entity Address, Postal Zip Code Restatement Determination Date Restatement Determination Date Share-Based Payment Arrangement [Abstract] CASH, CASH EQUIVALENTS, AND RESTRICTED CASH — Beginning of period CASH, CASH EQUIVALENTS, AND RESTRICTED CASH — End of period Total Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Income Statement [Abstract] Income tax provision (benefit) Income Tax Expense (Benefit) Government assistance, royalty and licensing expense, percentage of revenue (in percent) Government Assistance, Royalty And Licensing Expense, Percentage Of Revenue Government Assistance, Royalty And Licensing Expense, Percentage Of Revenue Sale of Stock [Domain] Sale of Stock [Domain] Current income tax liability Taxes Payable, Current Fair value of asset Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Product and Service [Domain] Product and Service [Domain] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Reportable Segment Reportable Segment [Member] Reportable Segment Property and equipment at cost Property, Plant and Equipment, Gross 2029 Lessor, Operating Lease, Payment to be Received, Year Three Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Proceeds from CIRM Grant Proceeds from Stock Options Exercised City Area Code City Area Code Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] All Trading Arrangements All Trading Arrangements [Member] Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Commitments and Contingencies Disclosure [Abstract] 2025 ATM Agreement 2025 ATM Agreement [Member] 2025 ATM Agreement Cash acquired through reverse recapitalization Cash Acquired Through Reverse Recapitalization Cash Acquired Through Reverse Recapitalization CASH FLOWS FROM INVESTING ACTIVITIES Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] General and administrative General and Administrative Expense Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation BKPBIOTECH, Inc. and JLSA2 Therapeutics, Inc. BKPBIOTECH, Inc. and JLSA2 Therapeutics, Inc. [Member] BKPBIOTECH, Inc. and JLSA2 Therapeutics, Inc. Related Party Transactions [Abstract] Preferred stock, par value per share (in dollars per share) Preferred Stock, Par or Stated Value Per Share Subsequent Event Subsequent Event [Member] Total lease cost Lease, Cost Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Schedule of Lease Cost Lease, Cost [Table Text Block] PEO Total Compensation Amount PEO Total Compensation Amount Depreciation Depreciation Money market funds Money Market Funds [Member] Aggregate offering price Sale of Stock, Consideration Receivable on Transaction Sale of Stock, Consideration Receivable on Transaction Lease Contractual Term [Axis] Lease Contractual Term [Axis] Numerator: Net Income (Loss) Available to Common Stockholders, Diluted [Abstract] Equity Components [Axis] Equity Components [Axis] Entity Ex Transition Period Entity Ex Transition Period Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] GeneFab sublease income - related party Total sublease income (expense) Sublease income Sublease Income Government assistance, repayment (in percent) Government Assistance, Repayment, Percent Government Assistance, Repayment, Percent Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Performance stock units outstanding Performance Stock Units [Member] Performance Stock Units Operating lease right-of-use assets Increase (Decrease) in Operating Lease, Right-Of-Use Asset Increase (Decrease) in Operating Lease, Right-Of-Use Asset Number of reportable segments Number of Reportable Segments Vesting of early exercise of common stock options Stock Issued During Period, Value, Vesting Of Early Exercise Of Stock Options Stock Issued During Period, Value, Vesting Of Early Exercise Of Stock Options Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost Other Performance Measure, Amount Other Performance Measure, Amount Schedule of Restrictions on Cash and Cash Equivalents Restrictions on Cash and Cash Equivalents [Table Text Block] Entity Address, State or Province Entity Address, State or Province Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Security, Excluded EPS Calculation [Table] Threshold days for repayment Government Assistance, Loan Conversion Option, Threshold Days For Repayment Government Assistance, Loan Conversion Option, Threshold Days For Repayment 2027 Lessor, Operating Lease, Payment to be Received, Year One Related Party [Domain] Related and Nonrelated Parties [Domain] Total current liabilities Liabilities, Current Government assistance, repayment, interest rate (in percent) Government Assistance, Repayment, Interest Rate, Percent Government Assistance, Repayment, Interest Rate, Percent Derivative Instrument [Axis] Derivative Instrument [Axis] Individual: Individual [Axis] Restricted cash Restricted cash Restricted Cash Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Abstract] Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Abstract] Research and development Research and Development Expense [Member] Entity [Domain] Entity [Domain] Net cash provided by investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Document Fiscal Year Focus Document Fiscal Year Focus Basis of Presentation and Principles of Consolidation Basis of Accounting, Policy [Policy Text Block] Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Option, installments, percentage of stock outstanding (in percent) Option Indexed to Issuer's Equity, Shares, Per Installment, Percentage Of Stock Outstanding Option Indexed to Issuer's Equity, Shares, Per Installment, Percentage Of Stock Outstanding Ownership percentage (in percent) Subsidiary, Ownership Percentage, Noncontrolling Owner Entity Interactive Data Current Entity Interactive Data Current Operating lease cost Operating Lease, Cost Government Assistance, Type [Axis] Government Assistance, Type [Axis] Plan Name [Domain] Plan Name [Domain] Back rent payment Lessor, Operating Lease, Payment to be Received, Back Rent Payment Lessor, Operating Lease, Payment to be Received, Back Rent Payment Equity [Abstract] New Enterprise Associates, Inc. (“NEA”) New Enterprise Associates, Inc. (“NEA”) [Member] New Enterprise Associates, Inc. (“NEA”) Segment Reporting Segment Reporting Disclosure [Text Block] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Shares issued upon conversion Convertible Preferred Stock, Shares Issued upon Conversion Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Ownership [Domain] Ownership [Domain] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Schedule of Maturities of Sublease Payments Lessor, Operating Lease, Payment to be Received, Maturity [Table Text Block] Maximum aggregate offering price Sale of Stock, Consideration To Be Received On Transaction Sale of Stock, Consideration To Be Received On Transaction Other non-current assets Other Assets, Noncurrent Entity Central Index Key Entity Central Index Key PEO Name PEO Name Aggregate purchase price Sale of Stock, Consideration Received on Transaction Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Facilities and other Facilities And Other [Member] Facilities And Other Arrangement Duration Trading Arrangement Duration Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Other Other Sundry Liabilities, Noncurrent Deferred revenue - related party Deferred revenue, current - related party Contract with Customer, Liability, Current Segments [Axis] Segments [Axis] Exercise price (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Beginning balance Ending balance Temporary Equity, Carrying Amount, Attributable to Parent Grant Grant [Member] Exercise Price Award Exercise Price Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Entity Filer Category Entity Filer Category Class of Stock [Domain] Class of Stock [Domain] Local Phone Number Local Phone Number Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Other non-cash charges Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Other Item Shares issuable (in dollars per share) Shares Issuable. Price Per Share Shares Issuable. Price Per Share Subsequent Event Type [Axis] Subsequent Event Type [Axis] Stock-based Compensation Share-Based Payment Arrangement [Text Block] Warrants, number of securities callable by warrants or rights (in shares) Class of Warrant or Right, Number of Securities Callable by Warrants or Rights Class of Warrant or Right, Number of Securities Callable by Warrants or Rights Professional and other service fees Accrued Professional Fees, Other, Current Accrued Professional Fees, Other, Current ASSETS Assets [Abstract] Credit Facility [Axis] Credit Facility [Axis] Nonrelated Party Nonrelated Party [Member] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Option, maximum purchase amount (in shares) Option Indexed to Issuer's Equity, Shares Debt Instrument [Axis] Debt Instrument [Axis] Fair Value Measurements Fair Value Disclosures [Text Block] Credit Facility [Domain] Credit Facility [Domain] STOCKHOLDERS’ EQUITY Equity, Attributable to Parent [Abstract] Additional advance payment commitment Additional Advance Payment Commitment Additional Advance Payment Commitment Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Entity Address, Address Line One Entity Address, Address Line One Research and development (including related party costs of $282 and $4,070 for the three months ended March 31, 2026 and 2025, respectively) Research and development Research and Development Expense Government assistance, royalty and licensing expense, per funding received Government Assistance, Royalty And Licensing Expense, Per Funding Received Government Assistance, Royalty And Licensing Expense, Per Funding Received Accrued expenses and other current liabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Net settlement of restricted stock units for employee taxes (shares) Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation Operating lease liabilities, non-current Operating Lease, Liability, Noncurrent Conversion of Series A convertible preferred stock to common stock (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Ownership [Axis] Ownership [Axis] Fair Value as of Grant Date Award Grant Date Fair Value Entity Registrant Name Entity Registrant Name Liabilities associated with CIRM Grant Government Assistance, Liability, Noncurrent Alameda Alameda [Member] Alameda Warrant exercises, allowable change in threshold percentage Class of Warrant or Right, Exercisable, Allowable Change In Threshold Percentage Class of Warrant or Right, Exercisable, Allowable Change In Threshold Percentage Beginning balance (in shares) Ending balance (in shares) Series A redeemable convertible preferred stock, outstanding (in shares) Temporary Equity, Shares Outstanding Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Contingent earnout common stock Contingent Earnout Common Stock [Member] Contingent Earnout Common Stock Option, exercise price (in dollars per share) Option Indexed to Issuer's Equity, Strike Price Related Party Transaction [Line Items] Related Party Transaction [Line Items] Document Quarterly Report Document Quarterly Report Contingent Consideration Receivable Contingent Consideration, Asset [Member] Contingent Consideration, Asset Total assets measured at fair value Assets, Fair Value Disclosure Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Counterparty Name [Domain] Counterparty Name [Domain] Number of operating segments Number of Operating Segments 2028 Lessee, Operating Lease, Liability, to be Paid, Year Two Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Schedule of Accrued Expenses and Other Current Liabilities Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Related Party [Axis] Related and Nonrelated Parties [Axis] Title Trading Arrangement, Individual Title Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount GeneFab sublease deferred income - related party Increase (Decrease) In Deferred Sublease Income Increase (Decrease) In Deferred Sublease Income Warrant exercises, stockholder approval threshold (in percent) Class of Warrant or Right, Exercisable, Stockholder Approval, Threshold Percentage Class of Warrant or Right, Exercisable, Stockholder Approval, Threshold Percentage Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Restatement Determination Date: Restatement Determination Date [Axis] Non-PEO NEO Non-PEO NEO [Member] Letters of credit Letters of Credit Outstanding, Amount Sale of Stock [Axis] Sale of Stock [Axis] Conversion price (in dollars per share) Temporary Equity, Redemption Price Per Share Name Trading Arrangement, Individual Name Award Type [Domain] Award Type [Domain] 2027 Lessee, Operating Lease, Liability, to be Paid, Year One Equity Awards Adjustments Equity Awards Adjustments [Member] Warrant exercises, allowable change in threshold percentage, prior notice term (in days) Class of Warrant or Right, Exercisable, Allowable Change In Threshold Percentage, Prior Notice Term Class of Warrant or Right, Exercisable, Allowable Change In Threshold Percentage, Prior Notice Term Leasehold improvements Leasehold Improvements [Member] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Sale of stock commission percentage on gross sales Sale Of Stock, Commission As Percentage Of Gross Proceeds Sale Of Stock, Commission As Percentage Of Gross Proceeds Compensation Amount Outstanding Recovery Compensation Amount Derivative Financial Instruments, Liabilities Derivative Financial Instruments, Liabilities [Member] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Name Awards Close in Time to MNPI Disclosures, Individual Name Advance payment, remaining amount Additional Advance Payment Commitment, Remaining Amount Additional Advance Payment Commitment, Remaining Amount Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Common stock shares available for future issuance under the 2022 Employee Stock Purchase Plan (the “ESPP”) 2022 Employee Stock Purchase Plan (the “2022 ESPP”) Employee Stock [Member] GeneFab GeneFab [Member] GeneFab Conversion of Series A redeemable convertible preferred stock to common stock Stock Issued During Period, Value, Conversion of Convertible Securities Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Financial Instruments [Domain] Financial Instruments [Domain] Liability Class [Axis] Liability Class [Axis] Option, maximum worth Option Indexed to Issuer's Equity, Shares, Value Option Indexed to Issuer's Equity, Shares, Value Segments [Domain] Segments [Domain] Statement of Income Location, Balance [Axis] Statement of Income Location, Balance [Axis] Cash and Cash Equivalent [Table] Cash and Cash Equivalent [Table] Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Sublease payments reduction fee Lessor, Operating Lease, Sublease Payments Lessor, Operating Lease, Sublease Payments Class of warrant or right, number of securities called by warrants or rights (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Minimum Minimum [Member] Certain Investor Certain Investor [Member] Certain Investor Less: accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Company Selected Measure Name Company Selected Measure Name Other non-current liabilities Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Accounts payable Accounts Payable, Current Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] All Executive Categories All Executive Categories [Member] Common stock, $0.0001 par value; 500,000,000 shares authorized as of both March 31, 2026 and December 31, 2025; 31,144,754 and 30,879,355 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively Common Stock, Value, Issued Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Weighted-average number of shares used in computing net loss per share, diluted (in shares) Weighted-average shares outstanding, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Commitments and contingencies (Note 13) Commitments and Contingencies Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Entity Small Business Entity Small Business Payment of issuance costs Payment of issuance costs Payments of Stock Issuance Costs Income Tax Disclosure [Abstract] Restricted Cash and Cash Equivalent Item [Line Items] Restricted Cash and Cash Equivalent Item [Line Items] Number of shares issuable in transaction (in shares) Sale of Stock, Number of Shares Issuable in Transaction Sale of Stock, Number of Shares Issuable in Transaction Document Transition Report Document Transition Report Conversion of Series A redeemable convertible preferred stock to common stock Temporary Equity, Conversion of Stock, Amount Converted Temporary Equity, Conversion of Stock, Amount Converted Rentable area Net Rentable Area Thereafter Lessor, Operating Lease, Payment to be Received, after Year Five Underlying Securities Award Underlying Securities Amount 2022 Equity Incentive Plan ( the “2022 EIP”) 2022 Equity Incentive Plan ( the “2022 EIP”) [Member] 2022 Equity Incentive Plan ( the “2022 EIP”) Equity Component [Domain] Equity Component [Domain] Other expense, net Other Nonoperating Expense Document Period End Date Document Period End Date PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Income Tax Income Tax Disclosure [Text Block] Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] GeneFab sublease deferred income - related party Deferred Sublease Income Deferred Sublease Income Senior Secured Convertible Notes Senior Secured Convertible Notes [Member] Senior Secured Convertible Notes Short-term lease cost Short-Term Lease, Cost Sublease income to be earned Lessor, Operating Lease, Sublease Payments To Be Received Lessor, Operating Lease, Sublease Payments To Be Received Operating lease liabilities Increase (Decrease) in Operating Lease Liability Senior Secured Convertible Notes, Additional Notes Senior Secured Convertible Notes, Additional Notes [Member] Senior Secured Convertible Notes, Additional Notes Document Type Document Type Level 3 Fair Value, Inputs, Level 3 [Member] Net Loss Per Share Earnings Per Share [Text Block] Name Outstanding Recovery, Individual Name Operating cash flows used for operating leases Operating Lease, Proceeds (Payments) Operating Lease, Proceeds (Payments) Additional paid-in capital Additional Paid in Capital Accrued expenses and other current liabilities Total accrued expenses and other current liabilities Accounts Payable and Other Accrued Liabilities, Current Product and Service [Axis] Product and Service [Axis] Derivative Contract [Domain] Derivative Contract [Domain] Variable lease cost Variable Lease, Cost Collaboration revenue - related party Revenue from Contract with Customer, Excluding Assessed Tax Collaborative Arrangement, Transaction with Party to Collaborative Arrangement Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member] All Individuals All Individuals [Member] Fair Value Disclosures [Abstract] Name Forgone Recovery, Individual Name Total current assets Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Sublease income - variable Operating Lease, Variable Lease Income Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Taxes paid related to net settlement of stock awards Payment, Tax Withholding, Share-Based Payment Arrangement Government assistance, co-funding obligation, amount Government Assistance, Co-Funding Obligation, Amount Government Assistance, Co-Funding Obligation, Amount Private Placement Private Placement [Member] Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] CURRENT LIABILITIES Liabilities, Current [Abstract] Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Total operating expenses Operating Expenses Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Level 1 Fair Value, Inputs, Level 1 [Member] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Convertible past due rent Lessor, Operating Lease, Payment to be Received, Convertible Amount Lessor, Operating Lease, Payment to be Received, Convertible Amount Revenue, remaining performance obligation, variable consideration, percentage of realized gains (in percent) Revenue, Remaining Performance Obligation, Variable Consideration, Percentage Of Realized Gains Revenue, Remaining Performance Obligation, Variable Consideration, Percentage Of Realized Gains Related Party Transaction [Table] Related Party Transaction [Table] Net loss per share, diluted (in dollars per share) Earnings Per Share, Diluted Vesting of early exercise of common stock options (in shares) Stock Issued During Period, Shares, Vesting Of Early Exercise Of Stock Options Stock Issued During Period, Shares, Vesting Of Early Exercise Of Stock Options Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] 2031 Lessor, Operating Lease, Payment to be Received, Year Five Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Title of 12(b) Security Title of 12(b) Security Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Issuable upon conversion (in shares) Preferred Stock, Convertible, Shares Issuable Number of shares issued (in shares) Sale of Stock, Number of Shares Issued in Transaction Award amount Government Assistance, Award Amount Earnings Per Share [Abstract] Common stock shares available for future issuance under equity plans Common Stock Under Equity Plans [Member] Common Stock Under Equity Plans 2031 Lessee, Operating Lease, Liability, to be Paid, Year Five Organization and Description of Business Business Description and Basis of Presentation [Text Block] Total other income Nonoperating Income (Expense) Corporate Headquarters Corporate Headquarters [Member] Corporate Headquarters Celadon Partners SPV 24 (“Celadon”) Celadon Partners SPV 24 (“Celadon”) [Member] Celadon Partners SPV 24 (“Celadon”) Grant transaction duration (in years) Government Assistance, Transaction Duration Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Government Assistance, Type [Domain] Government Assistance, Type [Domain] Less imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Cash and Cash Equivalents [Line Items] Cash and Cash Equivalents [Line Items] Restricted Cash and Cash Equivalents [Axis] Restricted Cash and Cash Equivalents [Axis] Award Timing Disclosures [Line Items] Employee-related expenses Employee-related Liabilities, Current Total undiscounted lease payments Lessee, Operating Lease, Liability, to be Paid Lease renewal term (in years) Lessee, Operating Lease, Renewal Term Number of seats on the board of directors Number of Seats On The Board Of Directors Number of Seats On The Board Of Directors Stockholders’ Equity Equity [Text Block] Net loss Net loss Net loss Net Income (Loss) Attributable to Parent Subsequent Event [Table] Subsequent Event [Table] Schedule of Sublease Income Operating Lease, Lease Income [Table Text Block] Expiration Date Trading Arrangement Expiration Date Sublease income - base rent Operating Lease, Lease Income, Lease Payments Other current liabilities Other Accrued Liabilities, Current Product Information [Line Items] Product Information [Line Items] Conversion of Series A convertible preferred stock to common stock (in shares) Temporary Equity, Conversion of Stock, Shares Converted Temporary Equity, Conversion of Stock, Shares Converted Restrictions on Cash and Cash Equivalents [Table] Restrictions on Cash and Cash Equivalents [Table] Property and equipment, net Property and equipment, net Property, Plant and Equipment, Net Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Adoption Date Trading Arrangement Adoption Date Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Reduction of certain operating expenses Gain (Loss) On Lease Modification, Operating Expenses Gain (Loss) On Lease Modification, Operating Expenses Accounts receivable Increase (Decrease) in Accounts Receivable Entity Current Reporting Status Entity Current Reporting Status Operating lease, term of contract (in years) Lessee, Operating Lease, Term of Contract Unpaid issuance costs Stock Issuance Costs Incurred But Not Paid Stock Issuance Costs Incurred But Not Paid Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Loss from operations Operating Income (Loss) Accumulated deficit Retained earnings (accumulated deficit) Retained Earnings (Accumulated Deficit) Financial Instrument [Axis] Financial Instrument [Axis] Adjustments to reconcile net loss to net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Noncash Item [Abstract] Statement of Financial Position [Abstract] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Executive Category: Executive Category [Axis] Class of Stock [Axis] Class of Stock [Axis] Senior Secured Convertible Notes, Initial Notes Senior Secured Convertible Notes, Initial Notes [Member] Senior Secured Convertible Notes, Initial Notes Current Fiscal Year End Date Current Fiscal Year End Date Bayer Bayer [Member] Bayer Decrease in operating lease liabilities resulting from lease remeasurement Decrease in operating lease liabilities resulting from lease remeasurement Increase (Decrease) In Operating Lease Liability, Remeasurement Increase (Decrease) In Operating Lease Liability, Remeasurement Subsequent Event Type [Domain] Subsequent Event Type [Domain] Number of business activities Number of Business Activities Number of Business Activities Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Other income, net Other nonoperating income (expense) Other Nonoperating Income (Expense) Statement [Table] Statement [Table] Derivative liability Derivative Liability 2022 Inducement Plan (the “2022 IN”) 2022 Inducement Plan (the “2022 IN”) [Member] 2022 Inducement Plan (the “2022 IN”) CASH FLOWS FROM FINANCING ACTIVITIES Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Upfront payment under research collaboration and license agreement Contract with Customer, Liability Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Cash and Cash Equivalents [Abstract] Celadon Partners, LLC Celadon Partners, LLC [Member] Celadon Partners, LLC Total Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Denominator: Weighted Average Number of Shares Outstanding, Diluted [Abstract] All Adjustments to Compensation All Adjustments to Compensation [Member] Amendment Flag Amendment Flag Price per share (in dollars per share) Sale of Stock, Price Per Share Authorized for issuance under share-based payment arrangement (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Depreciation and amortization Cost, Depreciation, Amortization and Depletion Operating Leases Lessee, Operating Leases [Text Block] Termination Date Trading Arrangement Termination Date Net cash used in financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Measure: Measure [Axis] Occurrence of default, annual interest accrual rate (in percent) Sale Of Stock, Default, Interest Rate Sale Of Stock, Default, Interest Rate Warrant exercise term, on or prior to original issuance date anniversary (in years) Class of Warrant or Right, Exercisable, On Or Prior To Original Issuance Date Anniversary, Term Class of Warrant or Right, Exercisable, On Or Prior To Original Issuance Date Anniversary, Term External services and supplies External Services And Supplies [Member] External Services And Supplies Weighted-average discount rate Operating Lease, Weighted Average Discount Rate, Percent Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Weighted-average number of shares used in computing net loss per share, basic (in shares) Weighted-average shares outstanding, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Related Party Transaction [Domain] Related Party Transaction [Domain] Subsequent Events [Abstract] Segment Reporting [Abstract] Equity Option Equity Option [Member] Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Other income: Nonoperating Income (Expense) [Abstract] Entity Tax Identification Number Entity Tax Identification Number Gain on lease modification Gain on lease modification Gain (Loss) On Lease Modification Gain (Loss) On Lease Modification Related And Nonrelated Parties Related And Nonrelated Parties [Member] Related And Nonrelated Parties Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Common stock, par or stated value (in dollars per share) Common Stock, Par or Stated Value Per Share Common stock, issued (in shares) Common Stock, Shares, Issued Cash, Cash Equivalents and Restricted Cash Cash and Cash Equivalents Disclosure [Text Block] Weighted-average remaining lease term (years) Operating Lease, Weighted Average Remaining Lease Term Use of Estimates Use of Estimates, Policy [Policy Text Block] Lab equipment Laboratory Equipment [Member] Laboratory Equipment Trading Arrangement: Trading Arrangement [Axis] Total Shareholder Return Amount Total Shareholder Return Amount Change in fair value of liability Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Subsequent Events Subsequent Events [Text Block] Insider Trading Arrangements [Line Items] Security Exchange Name Security Exchange Name 2028 Lessor, Operating Lease, Payment to be Received, Year Two TOTAL LIABILITIES Liabilities Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Purchases of property and equipment in accounts payable and accrued expenses Capital Expenditures Incurred but Not yet Paid Line of credit facility, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Prepaid expenses Prepaid Expense, Current Operating expenses: Operating Expenses [Abstract] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Redeemable Convertible Preferred Stock [Member] Redeemable Convertible Preferred Stock [Member] Asset Class [Domain] Asset Class [Domain] Change in fair value of asset Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings Increase (Decrease) in Temporary Equity [Roll Forward] Increase (Decrease) in Temporary Equity [Roll Forward] Statement [Line Items] Statement [Line Items] Personnel-related expenses, including stock-based compensation Personnel Related Expenses [Member] Personnel Related Expenses Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Cash and cash equivalents Cash and Cash Equivalent Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Counterparty Name [Axis] Counterparty Name [Axis] Subsequent Event [Line Items] Subsequent Event [Line Items] Number of additional shares authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Common Stock Common Stock [Member] Fair Value Debt Securities, Available-for-Sale Warrant exercises, beneficial ownership threshold (in percent) Class of Warrant or Right, Exercisable, Beneficial Ownership, Threshold Percentage Class of Warrant or Right, Exercisable, Beneficial Ownership, Threshold Percentage Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Non-NEOs Non-NEOs [Member] Option to terminate, closing threshold days Sale Of Stock, Option To Terminate, Closing Threshold Days Sale Of Stock, Option To Terminate, Closing Threshold Days NET DECREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation GeneFab Option GeneFab Option GeneFab Option [Member] GeneFab Option